Edited by Ana Carrizosa Anderson and Dario VignaliInspired by the SITC session “Immune Checkpoints – Beyond PD-1,” JITC continues the impetus of recognizing a widening range of checkpoint targets that are advancing the field forward. Comprised of several authoritative reviews of checkpoints beyond PD-1, this series promotes the tremendous research that is opening new pathways for treating patients with cancer.